Interview with Julie Masse, International Business Developer at Galchimia
For two days, beginning on the 5th July, the 53rd edition of the International Conference on Medicinal Chemistry (RICT 2017), organised by The French Medicinal Chemistry Society (SCT), will be held in the French city of Toulouse.
The congress will be devoted to “Drug Discovery & Selection”, an area in which GalChimia has considerable experience, according their CEO, Carme Pampin, and the main topics will be: Immunotherapy-Oncology, Emerging and Neglected Diseases, Breakthrough in Technologies for Drug Discovery, Tackling the Delivery of Biologics and Access to Novel Molecular Entities.
In the interview with the person in charge of driving the Galchimia internationalisation Julie Masse, who is International Business Developer explained the importance of attending events like this one, the internationalisation of GalChimia, the international positioning of the company, and its strengths with respect to competitors.
Access the original article to read the full interview